Fee Bengsch
Iomedico (Germany)(DE)
Publications by Year
Research Areas
Ubiquitin and proteasome pathways, Histone Deacetylase Inhibitors Research, Cancer, Hypoxia, and Metabolism, Protease and Inhibitor Mechanisms, Cell Adhesion Molecules Research
Most-Cited Works
- → BET Bromodomain Inhibition Promotes Anti-tumor Immunity by Suppressing PD-L1 Expression(2016)425 cited
- → Genetically Engineered Mouse Models of Pancreatic Cancer: The KPC Model (LSL‐KrasG12D/+;LSL‐Trp53R172H/+;Pdx‐1‐Cre), Its Variants, and Their Application in Immuno‐oncology Drug Discovery(2016)197 cited
- → Cell type-dependent pathogenic functions of overexpressed human cathepsin B in murine breast cancer progression(2013)105 cited
- → CTLA-4/CD80 pathway regulates T cell infiltration into pancreatic cancer(2017)104 cited
- → Deletion of Cysteine Cathepsins B or L Yields Differential Impacts on Murine Skin Proteome and Degradome(2012)40 cited
- → Comprehensive analysis of the ubiquitinome during oncogene-induced senescence in human fibroblasts(2015)28 cited
- → Cathepsin proteases promote angiogenic sprouting and laser-induced choroidal neovascularisation in mice(2013)20 cited
- → Proteolysis-a characteristic of tumor-initiating cells in murine metastatic breast cancer(2016)8 cited
- → Final Results from RIBBIT: A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib in Combination with Endocrine Therapy or Chemotherapy with or without Bevacizumab in the First-Line Setting(2023)3 cited
- → The INFINITY study protocol: a retrospective cohort study on decision making and clinical impact of biomarker-driven precision oncology in routine clinical practice(2023)1 cited